CD44v reportedly also increased cellular GSH content by enhancing its biosynthesis in gastric cancer.18 Because CD44s lacks the domain interacting with xCT, which is required for the enhancement of GSH biosynthesis by CD44v, it has been unclear whether CD44s regulates redox status in HCC. The gene discussed is SLC7A11; the disease is hepatocellular carcinoma.